DYNE THERAPEUTICS INC's ticker is DYN and the CUSIP is 26818M108. A total of 95 filers reported holding DYNE THERAPEUTICS INC in Q1 2022. The put-call ratio across all filers is - and the average weighting 0.6%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2022 | $1,828,346 | -68.4% | 157,752 | -73.7% | 0.00% | -100.0% |
| Q1 2022 | $5,784,000 | -30.8% | 600,000 | -14.7% | 0.00% | -50.0% |
| Q4 2021 | $8,363,000 | -28.2% | 703,400 | -1.9% | 0.00% | -33.3% |
| Q3 2021 | $11,646,000 | -7.7% | 717,100 | +19.5% | 0.00% | 0.0% |
| Q2 2021 | $12,624,000 | +35.5% | 600,000 | 0.0% | 0.00% | +50.0% |
| Q1 2021 | $9,318,000 | +10.9% | 600,000 | +50.0% | 0.00% | 0.0% |
| Q4 2020 | $8,400,000 | -13.5% | 400,000 | -16.8% | 0.00% | -33.3% |
| Q3 2020 | $9,707,000 | – | 480,769 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Vida Ventures Advisors, LLC | 2,960,046 | $28,535,000 | 16.60% |
| MPM ASSET MANAGEMENT LLC | 4,951,303 | $47,731,000 | 16.31% |
| Atlas Venture Life Science Advisors, LLC | 8,934,902 | $86,132,000 | 10.89% |
| Logos Global Management LP | 2,734,392 | $26,360,000 | 3.42% |
| Deep Track Capital, LP | 3,500,000 | $33,740,000 | 2.16% |
| Octagon Capital Advisors LP | 525,284 | $5,064,000 | 1.10% |
| HighVista Strategies LLC | 168,691 | $1,626,000 | 1.03% |
| Monashee Investment Management LLC | 279,704 | $2,696,000 | 0.78% |
| COMMODORE CAPITAL LP | 305,125 | $2,941,000 | 0.66% |
| RA Capital Management | 2,805,045 | $27,041,000 | 0.59% |